News
The Centre Approved Biological E's Corbevax as a Heterologous Precaution Dose for Adults ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'The Centre approved Biological E's Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin, said a source.@MoHFW_INDIA'
The Centre approved Biological E's Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin, said a source.@MoHFW_INDIA pic.twitter.com/DnPAYdXuSJ— IANS (@ians_india) August 10, 2022
(The above story first appeared on LatestLY on Aug 10, 2022 12:28 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
